PRESS RELEASE published on 02/22/2023 at 22:05, 1 year 9 months ago Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA(R) (pembrolizumab), was Granted Breakthrough Therapy Designation by the FDA for Adjuvant Treatment of Patients With High-Risk Mela
PRESS RELEASE published on 02/22/2023 at 13:00, 1 year 9 months ago Moderna And Life Edit Therapeutics Enter Strategic Collaboration to Accelerate the Development of Novel In Vivo Gene Editing Therapies
PRESS RELEASE published on 02/17/2023 at 17:00, 1 year 9 months ago Health Canada Authorizes Moderna's Omicron-Targeting Bivalent COVID-19 Vaccine in Children & Adolescents (6-17 Years)
PRESS RELEASE published on 02/16/2023 at 22:05, 1 year 9 months ago Moderna Announces Interim Phase 3 Safety and Immunogenicity Results for mRNA-1010, a Seasonal Influenza Vaccine Candidate
PRESS RELEASE published on 02/02/2023 at 13:00, 1 year 9 months ago Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023
PRESS RELEASE published on 01/30/2023 at 13:15, 1 year 9 months ago Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate
PRESS RELEASE published on 01/17/2023 at 22:05, 1 year 10 months ago Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older Adults
PRESS RELEASE published on 01/09/2023 at 13:00, 1 year 10 months ago Moderna Announces Advances Across mRNA Pipeline and Provides Business Update
PRESS RELEASE published on 01/05/2023 at 22:05, 1 year 10 months ago Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Published on 11/25/2024 at 20:00, 55 minutes ago The Official VHA-H: Hoverfly Spectre Secures Variable Height Antenna - Heavy (VHA-H) Program for U.S. Army
Published on 11/25/2024 at 19:45, 1 hour 10 minutes ago Juva Life Inc. Updates Shareholders on Court-Appointed Receivership Proceedings
Published on 11/25/2024 at 18:35, 2 hours 20 minutes ago CANEX Closes Final Tranche of Equity Financing
Published on 11/25/2024 at 16:50, 4 hours 5 minutes ago Tecogen Receives Orders for 7 DTX Chillers for Las Vegas Convention Center
Published on 11/25/2024 at 20:35, 20 minutes ago Launch of World Advanced Manufacturing & Logistics Expo & Summit (WAM Morocco) 2025 to Advance the Country’s Shift Towards Next-Generation Industries and High-Value Manufacturing
Published on 11/25/2024 at 20:35, 20 minutes ago World Advanced Manufacturing & Logistics Expo & Summit (WAM Morocco) 2025 : Le Maroc se positionne comme leader des industries de nouvelle génération
Published on 11/25/2024 at 20:34, 20 minutes ago Avolta wins new ten-year contract, adds Manaus Airport to Brazil portfolio
Published on 11/25/2024 at 19:00, 1 hour 55 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 18 NOVEMBRE 2024 au 22 NOVEMBRE 2024
Published on 11/25/2024 at 18:00, 2 hours 55 minutes ago Chiffre d’affaires consolidé 2023-2024 : 91 M€ en repli de 9,4 %
Published on 11/25/2024 at 17:55, 3 hours ago Déclaration des transactions sur actions propres réalisées du 18/11/2024 au 22/11/2024
Published on 11/25/2024 at 17:55, 3 hours ago Disclosure of trading in own shares from 18/11/2024 to 22/11/2024
Published on 11/25/2024 at 17:45, 3 hours 9 minutes ago Reporting on share buyback transactions carried out between November 19 and November 22, 2024
Published on 11/25/2024 at 17:45, 3 hours 9 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 19 et le 22 novembre 2024
